Annual Capital Investment for Research Call

Andrew Gwynne Excerpts

Monday 7th October 2024 Written Statements

[The Parliamentary Under-Secretary of State for Health and Social Care (Andrew Gwynne)]

My noble Friend the Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health (Baroness Merron) has made the following statement:

Today I am pleased to announce Department of Health and Social Care (DHSC) funding of nearly £30 million through the National Institute for Health and Care Research (NIHR) for capital equipment, technology and modular buildings to support NHS trusts in England to deliver high-quality research to improve the health of the population.

This large-scale investment will support 36 NHS trusts to develop and deliver research which aims to reduce early death from major conditions and improve access to high-quality health and care. The funding will increase NHS capacity to deliver commercial clinical trials which bring innovative medicines to patients earlier and maximise our potential to lead the world in clinical trials. This includes investment in modular buildings to expand the footprint for research in hospitals, many of which are in rural and coastal areas. It is important that everyone, regardless of where they live, can access the latest innovations in the health and care system through research.

Funding is going to NHS trusts the length and breadth of England, from Harrogate to Plymouth. A mobile research unit in Hull will increase participation in trials in East Yorkshire; and modular buildings will expand capacity for clinical research in Bradford, Essex, Exeter and Derby.

Walsall Healthcare NHS Trust is receiving funding for a mobile X-ray unit to increase their capability to carry out trials that are normally only available in large research units. This is a huge step forward for a district general hospital, bringing research closer to the communities which they serve.

Alder Hey Children’s NHS Foundation Trust were successful in their application for funding for equipment which applies red and near infrared light to injuries or lesions to improve wound and soft tissue healing. This will allow children to participate in studies at their regular clinic, reducing travel and reaching underserved communities.

Southern Health NHS Foundation Trust and East Lancashire Hospitals NHS Trust will expand their capacity for commercial trials in conditions such as dementia with a stand-alone pharmacy space and a pharmacy dispensary, respectively, to enable studies in new medicines. The Royal Marsden have received funding for equipment to increase capability and capacity in advanced therapy areas in oncology across commercial and non-commercial portfolios.

This significant funding will support cutting edge research to improve population health and support commercial research delivery in NHS settings for both the benefit of patients but also the economic growth of the country, positioning the UK as an attractive place for innovative companies to invest in research.

While the equipment or technology is primarily for research, when not in use in this way, equipment such as MRI Scanners will be used for clinical care. This will bolster the capacity of the health system to carry out procedures such as diagnostic testing to inform care and reduce the time taken to treatment, maximising the benefit from this investment.

[HCWS107]